✦ LIBER ✦

Immune correlates of metastatic melanoma patients treated with ipilimumab in combination with fotemustine in the phase II NIBIT-M1 study

✍ Scribed by Cristina Maccalli,Hugues Nicolay…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

9305 ORAL A Phase II Study Combining Ipi

✍ Pi Giacomo, A.M.; Ascierto, P.A.; Pittiglio, E.; Queirolo, P.; Pilla, L.; Ridolf 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Ipilimumab and fotemustine in patients w

✍ Anna Maria Di Giacomo; Paolo A Ascierto; Lorenzo Pilla; Mario Santinami; Pier Fr 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 177 KB

A phase II study of extended dose temozo

✍ Damian A. Laber; Roseline I. Okeke; Carlos Arce-Lara; Beverly S. Taft; Cassandra 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 255 KB

Phase II study of ifosfamide plus vinore

✍ F. Lobo; A. Frau; A. Barnadas; M. Méndez; J. Lizón; M. Provencio; J. J. Albistur 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 73 KB

Phase I study of the combination of doce

✍ Kevin B. Kim; Wen-Jen Hwu; Nicholas E. Papadopoulos; Agop Y. Bedikian; Luis H. C 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 268 KB

Phase II study of vindesine and dacarbaz

✍ Verschraegen, C.F.; Legha, S.S.; Hersh, E.M.; Plager, C.; Papadopoulos, N.; Burg 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 424 KB